Oncolytics Biotech
ONCY
#9313
Rank
S$0.12 B
Marketcap
S$1.13
Share price
5.89%
Change (1 day)
6.35%
Change (1 year)

Earnings for Oncolytics Biotech (ONCY)

Earnings in 2025 (TTM): -S$32.68 Million

According to Oncolytics Biotech 's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -S$32.34 Million a decrease over its 2023 earnings that were of -S$32.01 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Oncolytics Biotech from 2001 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -S$32.68 Million1.08%
2024 -S$32.34 Million1.01%
2023 -S$32.01 Million23.39%
2022 -S$25.94 Million-1.98%
2021 -S$26.47 Million9.1%
2020 -S$24.26 Million22.64%
2019 -S$19.78 Million22.78%
2018 -S$16.11 Million4.1%
2017 -S$15.48 Million4.87%
2016 -S$14.76 Million8.75%
2015 -S$13.57 Million-37.06%
2014 -S$21.56 Million-26.2%
2013 -S$29.21 Million-37.39%
2012 -S$46.66 Million28.8%
2011 -S$36.23 Million46.02%
2010 -S$24.81 Million35.64%
2009 -S$18.29 Million-14.2%
2008 -S$21.32 Million-0.52%
2007 -S$21.43 Million24.6%
2006 -S$17.2 Million45.34%
2005 -S$11.84 Million-11.8%
2004 -S$13.42 Million115.36%
2003 -S$6.23 Million13.86%
2002 -S$5.48 Million-5.45%
2001 -S$5.79 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Eli Lilly
LLY
S$28.59 B-90,559.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$10.20 B-32,390.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Mirati Therapeutics
MRTX
-S$0.98 Billion 2,974.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Aeterna Zentaris
AEZS
-S$6.98 Million-77.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
S$2.25 B-7,223.05%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
AVEO Oncology
AVEO
-S$36.9 Million 16.73%๐Ÿ‡บ๐Ÿ‡ธ USA